Can erythropoietin improve tumor oxygenation?

Strahlentherapie und Onkologie

Volumn 174, Issue SUPPL. 4, 1998, Pages 20-23

  Kelleher, Debra K ^a   Thews, Oliver ^a   Vaupel, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anemia; Erythropoietin; Hypoxia; Oxygenation; Radiosensitivity; Radiotherapy

Indexed keywords

CARBOPLATIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL MODEL; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEMOGLOBIN DETERMINATION; HYPOXIA; NONHUMAN; OXYGENATION; RADIOSENSITIVITY; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR;

ANEMIA; ANIMALS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; OXYGEN CONSUMPTION; RADIATION TOLERANCE;

EID: 0031790609     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Abels RI, Larholt KM, Krantz KD, et al. Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer. In: Murphy MJ, ed. Blood cell growth factors: Their present and future use in hematology and oncology. Dayton: AlphaMed Press, 1991:121-41.
2. Bajetta E, Di Bartolomeo M, Buzzoni R, et al. Recombinant human erythropoietin (rHuEPO) in the treatment of anemia associated with solid tumors with or without bone marrow infiltration. Int J Oncol 1993;3:1121-6.
3. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
4. Case DC, Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993;85:801-6.
5. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1998;14:831-8.
6. Grau C, Overgaard J. Significance of hemoglobin concentration for treatment outcome. In: Molls M, Vaupel P, eds. Medical radiology - Diagnostic imaging and radiation oncology. Blood perfusion and microenvironment of human tumors. Implications for clinical radiooncology. Berlin-Heidelberg-New York: Springer, 1998:101-12.
7. Höckel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
8. Höckel M, Vaupel P. The prognostic significance of hypoxia in cervical cancer: A radiobiological or tumor biological phenomenon? In: Molls M, Vaupel P, eds. Medical radiology - Diagnostic imaging and radiation oncology. Blood perfusion and microenvironment of human rumors. Implications for clinical radiooncology. Berlin-Heidelberg-New York: Springer, 1998:73-9.
9. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
10. Joiner B, Hirst VK, McKeown SR, et al. The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer 1993;68:720-6.
11. Kelleher DK, Matthiensen U, Thews O, et al. Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol 1995;34:379-84.
12. Kelleher DK, Matthiensen U, Thews O, et al. Blood flow, oxygenation and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res 1996;56:4728-34.
13. Lavey RS, Dempsey WH. Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27:1147-52.
14. Levine EA, Vijayakamur S. Blood transfusion in patients receiving radical radiotherapy: a reappraisal. Onkologie 1993;16:79-87.
15. McCormack M, Nias AHW, Smith E. Chronic anaemia hyperbaric oxygen and tumor radiosensitivity. Br J Radiol 1990;63:752-9.
16. Millar CB, Platanias LC, Mills SR, et al. Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 1992;84:98-103.
17. Nordsmark M, Overgaard M, Overggard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
18. Sutherland RM, Ausserer WA, Murphy BJ, et al. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiol Oncol 1996;6:59-70.
19. Thews O, Koenig R, Kelleher DK, et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 1998;78:752-6.
20. Vaupel P. Oxygenation of solid tumors. In: Teicher BA, ed. Drug resistance in oncology. New York-Basel: Marcel Dekker, 1993:53-85.
21. Vaupel P. The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin Pädiatr 1997;209:243-9.
22. Vaupel P, Höckel M. Oxygenation of human tumors. In: Molls M, Vaupel P, eds. Medical radiology - Diagnostic imaging and radiation oncology. Blood perfusion and microenvironment of human tumors. Implications for clinical radiooncology. Berlin-Heidelberg-New York: Springer, 1998: 63-72.
23. 2 tension measurements. Cancer Res 1991;51:3316-22.
24. Vaupel P, Thews O, Hoeckel M. Tumor oxygenation: Characterization and clinical implications. In: Smyth JF, Boogaerts MA, Ehmer BR-M, eds. RhErythropoietin in cancer supportive treatment. New York-Basel: Marcel Dekker, 1996:205-39.
25. Vijayakumar S, Roach M, Wara W, et al. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial. Int J Radiat Oncol Biol Phys 1993;26:721-9.